PDL BioPharma, Inc. EPS (Basic, from Continuous Ops)

EPS (Basic, from Continuous Ops) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, from Continuous Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, from Continuous Ops) for the quarter ending June 29, 2020 was -0.11 (a -57.69% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, from Continuous Ops) decreased by -30.82%
  • Annual EPS (Basic, from Continuous Ops) for 2019 was -0.6 (a 26.06% increase from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2018 was -0.47 (a -166.35% decrease from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2017 was 0.71 (a 83.32% increase from previous year)
  • Twelve month EPS (Basic, from Continuous Ops) ending June 29, 2020 was -0.83 (a 5.09% increase compared to previous quarter)
  • Twelve month trailing EPS (Basic, from Continuous Ops) increased by 320.31% year-over-year
Trailing EPS (Basic, from Continuous Ops) for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-0.83 -0.79 -0.6 -0.2
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, from Continuous Ops) of PDL BioPharma, Inc.

Most recent EPS (Basic, from Continuous Ops)of PDLI including historical data for past 10 years.

Interactive Chart of EPS (Basic, from Continuous Ops) of PDL BioPharma, Inc.

PDL BioPharma, Inc. EPS (Basic, from Continuous Ops) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -0.11 -0.26
2019 -0.3 -0.16 -0.07 -0.07 -0.6
2018 0.1 0.18 -0.76 0.01 -0.47
2017 0.14 0.14 0.39 0.04 0.71
2016 -0.06 0.08 0.03 0.34 0.39
2015 0.61 0.42 0.48 0.52 2.04
2014 0.34 0.64 0.57 0.48 2.04
2013 0.44 0.4 0.67 0.38 1.89
2012 0.35 0.35 0.53 0.29 1.52
2011 0.28 0.33 0.5 0.32 1.43
2010 -0.23 0.32 0.42 0.73

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.